All Content

Patients with non-high-risk APL can achieve better clinical outcomes when treated with ATRA plus arsenic trioxide compared with ATRA plus chemotherapy, a new study found.

Using a simple questionnaire to assess anxiety in breast cancer patients before surgery may help alleviate patients’ fear and uncertainty, and improve outcomes.

A 57-year-old man presents with symptoms of pain in the sacral area. A mass is resected. What is your diagnosis?

Breast Cancer Awareness Month is a magical time that brings out the child in each of us. You can keep your Santa Claus and your Tooth Fairy, I believe in the warm and fuzzy feeling of breast cancer awareness.

Individualized counseling should begin before surgery and continue throughout treatment for breast cancer survivors fearful of developing lymphedema, says a new study.

Two French studies have shown that screening for colorectal cancer with fecal occult blood tests can be very effective, according to results presented at the ESMO 2014 Congress.

Combining BRAF and MEK inhibitors resulted in better response, PFS, and overall survival compared with a BRAF inhibitor alone in BRAF-positive melanoma patients, according to results presented at the 2014 ESMO Congress.

Rolapitant added to granisetron/dexamethasone helped prevented chemotherapy-induced nausea and vomiting in patients treated with cisplatin-based chemotherapy, according to a study at the ESMO 2014 Congress.

In patients with recurrent or metastatic head and neck squamous cell carcinoma, afatinib better delayed cancer progression compared with methotrexate, according to results presented at the 2014 ESMO Congress.

Data from the CLEOPATRA trial show that pertuzumab adds nearly 16 months to median survival times when used with trastuzumab and chemo in HER2-positive breast cancer, according to final results presented at the ESMO 2014 Congress.


By clicking Accept, you agree to become a member of the UBM Medica Community.